Cationic anti-microbial peptides:: from innate immunity study to drug development

被引:14
作者
Andrès, E
Dimarcq, JL
机构
[1] CNRS, Inst Biol Mol & Cellulaire, UPR 9022, F-67000 Strasbourg, France
[2] EntoMed SA, F-67400 Illkirch Graffenstaden, France
来源
REVUE DE MEDECINE INTERNE | 2004年 / 25卷 / 09期
关键词
anti-microbial peptides; innate immunity; infections; drugs;
D O I
10.1016/j.revmed.2004.02.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. - Host defense, cationic anti-microbial peptides are recognized as an important component of innate immune response in most multicellular organisms. New features. - They are cationic amphipathic peptides, comprising 20-50 amino acids. Several hundreds of peptides have been characterized. They have broad spectrum of activity against bacterial, fungal and viral pathogens. The mode of action is best known for cecropins and magainins, which act upon the cytoplasmic membrane of microorganisms, causing its disruption by a detergent like activity and pore formation, Several of these peptides or analogs (from magainin, protegrin, indolicidin and histatin) are in advanced clinical development, especially for localized infections. Projects and perspectives. - Several other molecules (rBPI, heliomicin and thanatine) are currently under development for various systemic infections. They may represent important drugs of the further anti-infectious therapeutic arsenal. (C) 2004 Elsevier SAS. Tous droits reserves.
引用
收藏
页码:629 / 635
页数:7
相关论文
共 45 条
  • [1] Cationic antimicrobial peptides:: update of clinical development
    Andrès, E
    Dimarcq, JL
    [J]. JOURNAL OF INTERNAL MEDICINE, 2004, 255 (04) : 519 - 520
  • [2] ANDRES E, 2001, ANTIBIOTIQUES, V3, P201
  • [3] Protegrins: new antibiotics of mammalian origin
    Bellm, L
    Lehrer, RI
    Ganz, T
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (08) : 1731 - 1742
  • [4] MAGAININS - A NEW FAMILY OF MEMBRANE-ACTIVE HOST DEFENSE PEPTIDES
    BERKOWITZ, BA
    BEVINS, CL
    ZASLOFF, MA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 39 (04) : 625 - 629
  • [5] Antibacterial peptides: basic facts and emerging concepts
    Boman, HG
    [J]. JOURNAL OF INTERNAL MEDICINE, 2003, 254 (03) : 197 - 215
  • [6] Boman HG, 1998, SCAND J IMMUNOL, V48, P15
  • [7] The new antibiotics
    Breithaupt, H
    [J]. NATURE BIOTECHNOLOGY, 1999, 17 (12) : 1165 - 1169
  • [8] Antimicrobial peptides in insects; structure and function
    Bulet, P
    Hetru, C
    Dimarcq, JL
    Hoffmann, D
    [J]. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 1999, 23 (4-5) : 329 - 344
  • [9] COCIANCICH S, 1993, J BIOL CHEM, V268, P19239
  • [10] Bactericidal/permeability-increasing protein [rBPI21] in patients with hemorrhage due to trauma:: Results of a multicenter phase II clinical trial
    Demetriades, D
    Smith, JS
    Jacobson, LE
    Moncure, M
    Minei, J
    Nelson, BJ
    Scannon, PJ
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1999, 46 (04) : 667 - 676